These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10459932)

  • 1. Beta-blockers in heart failure.
    Lindsay J; Freemantle N; Nazareth I
    Lancet; 1999 Mar; 353(9157):1011-2. PubMed ID: 10459932
    [No Abstract]   [Full Text] [Related]  

  • 2. Heart failure management. Interview with Karl Swedberg.
    Swedberg K
    Timely Top Med Cardiovasc Dis; 2007 Jan; 11():E1. PubMed ID: 17369884
    [No Abstract]   [Full Text] [Related]  

  • 3. The evidence for beta blockers in heart failure.
    Cleland JG; McGowan J; Clark A; Freemantle N
    BMJ; 1999 Mar; 318(7187):824-5. PubMed ID: 10092240
    [No Abstract]   [Full Text] [Related]  

  • 4. [Angiotensin receptor blockers in heart failure. CHARM Study].
    Kochsiek K
    Internist (Berl); 2004 Sep; 45(9):1063-7. PubMed ID: 15309315
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of angiotensin receptor blockers in heart failure: not yet RESOLVD.
    Greenberg BH
    Circulation; 1999 Sep; 100(10):1032-4. PubMed ID: 10477526
    [No Abstract]   [Full Text] [Related]  

  • 6. Promise of mineralocorticoid receptor blockade in asymptomatic left ventricular dysfunction.
    Pitt B
    Hypertension; 2007 Sep; 50(3):461-2. PubMed ID: 17635849
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
    Kubota T; Takeshita A
    Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conclusions on the management of heart failure.
    Swedberg K
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S34-6. PubMed ID: 15526241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis for therapeutic choices in heart failure.
    Opie LH
    Circulation; 2004 Oct; 110(17):2559-61. PubMed ID: 15505109
    [No Abstract]   [Full Text] [Related]  

  • 10. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
    Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
    Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL; Ahmed A
    J Am Coll Cardiol; 2004 Apr; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract]   [Full Text] [Related]  

  • 12. Out-patient management of chronic heart failure.
    Terrovitis JV; Anastasiou-Nana MI; Nanas JN
    Expert Opin Pharmacother; 2005 Sep; 6(11):1857-81. PubMed ID: 16144507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic management of heart failure and left ventricular dysfunction following acute myocardial infarction in French intensive care units].
    Cambou JP; Vicaut E; Papadopoulos-Degrandsart A; Danchin N
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):36-41. PubMed ID: 17343037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reassessing guidelines for heart failure.
    Drexler H; Wollert KC
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5 Suppl 1():S28-33. PubMed ID: 15526240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy versus implantable cardioverter -defibrillator in preventing sudden cardiac death in patients with left ventricular systolic dysfunction and heart failure: a meta-analysis of > 35,000 patients.
    Peck KY; Lim YZ; Hopper I; Krum H
    Int J Cardiol; 2014 May; 173(2):197-203. PubMed ID: 24636548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I; Liu P; Webb G
    Int J Cardiol; 2004 Dec; 97 Suppl 1():25-33. PubMed ID: 15590076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacologic treatment of heart failure in the elderly].
    Erdmann E
    Dtsch Med Wochenschr; 2013 Apr; 138(14):700-2. PubMed ID: 23533033
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug treatment for chronic heart failure with reduced ejection fraction].
    Rickenbacher P
    Ther Umsch; 2011 Feb; 68(2):71-9. PubMed ID: 21271537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Betablockers and the treatment of chronic heart failure].
    Martínez Martínez JA
    Medicina (B Aires); 1999; 59(6):793-7. PubMed ID: 10752230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.